Healthcare Services

Oligonucleotide Synthesis Market Forecast 2026: Where the Industry Is Headed

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the oligonucleotide synthesis market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Oligonucleotide Synthesis Market reach by 2030 starting from 2026 levels?

The oligonucleotide synthesis market has seen rapid expansion in its size over recent years. Projections indicate it will increase from $11.92 billion in 2025 to $13.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.6%. Historically, this growth stemmed from factors such as the high cost of synthesis equipment, limited availability of custom oligos, reliance on manual synthesis processes, low awareness among researchers, and extended production timelines.

The oligonucleotide synthesis market is poised for significant expansion in the next few years, with its size projected to reach $26.08 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.1%. This growth during the forecast period is attributed to factors such as increasing demand from therapeutic and diagnostic applications, the rising adoption of automated synthesis platforms, advancements in gene therapy research, heightened investment in biotechnology research, and the global expansion of oligo-based research and diagnostics. Key trends expected include developments in gene editing and personalized medicine, the integration of cloud-based data management platforms, the application of AI for sequence optimization and design, increased automation in oligonucleotide synthesis processes, and IoT-enabled equipment monitoring and process tracking.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

Which Drivers Are Influencing Long-Term Growth In The Oligonucleotide Synthesis Market?

The increasing occurrence of chronic illnesses is anticipated to propel the expansion of the oligonucleotide synthesis market. These conditions are defined as lasting a year or more, necessitating ongoing medical attention, and potentially deteriorating over time. Through diverse mechanisms, oligonucleotides influence the gene expression responsible for chronic diseases. Their action involves targeting mRNA, pre-mRNA, or non-coding RNA to regulate splicing, initiate degradation, or disrupt protein translation. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, new cancer cases would exceed 35 million, representing a 77% increase compared to the estimated 20 million cases in 2022. Consequently, the expanding occurrence of both chronic and rare diseases is fueling the development of the oligonucleotide synthesis market.

Which Segments Are Driving Activity In The Oligonucleotide Synthesis Market?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Solution Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

What Trends Are Reshaping The Dynamics Of The Oligonucleotide Synthesis Market?

Leading companies within the oligonucleotide synthesis market are prioritizing the creation of innovative DNA products aimed at improving sequence accuracy, streamlining workflows, and supporting advanced research applications. For example, in July 2024, Ansa Biotechnologies, Inc., a US-based company specializing in complex DNA manufacturing, introduced Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA supplies clonal, sequence-perfect DNA up to 600 base pairs in length, thus removing the necessity for assembly and delivering exceptional accuracy for intricate synthetic biology projects. This product guarantees error-free, ready-to-use DNA sequences, making it a trustworthy selection for researchers. Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments, also up to 600 base pairs, specifically designed for various research applications. Through its cutting-edge enzymatic synthesis process, Ansa consistently produces complex DNA constructs, including repeats and secondary structures, with high precision.

Which Key Players Are Driving Competition In The Oligonucleotide Synthesis Market?

Major companies operating in the oligonucleotide synthesis market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Which Region Currently Holds The Largest Share Of The Oligonucleotide Synthesis Market?

North America was the largest region in the oligonucleotide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oligonucleotide Synthesis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Synthesis Market 2026, By The Business Research Company

Peptide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Gene Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795